Citadel Advisors - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is and the CUSIP is 88322Q908. A total of 3 filers reported holding TG THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$148,000
-22.5%
17,400
+8.8%
0.00%
Q4 2015$191,000
+198.4%
16,000
+154.0%
0.00%
Q3 2015$64,000
-81.2%
6,300
-69.3%
0.00%
Q2 2015$340,000
+9.3%
20,500
+2.0%
0.00%
Q1 2015$311,000
-45.1%
20,100
-43.9%
0.00%
-100.0%
Q4 2014$567,000
-2.9%
35,800
-34.6%
0.00%0.0%
Q3 2014$584,000
+39.4%
54,700
+22.6%
0.00%
Q2 2014$419,000
+3391.7%
44,600
+2377.8%
0.00%
Q1 2014$12,000
+9.1%
1,800
-33.3%
0.00%
Q4 2013$11,0002,7000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Antara Capital LP 294,600$15,325,0003.18%
GROUP ONE TRADING, L.P. 758,500$39,457,0000.07%
SIMPLEX TRADING, LLC 560$2,913,0000.00%
JPMORGAN CHASE & CO 25,300$1,316,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of TG THERAPEUTICS INC shareholders